These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 17695473)
41. Do polymorphisms and haplotypes of mismatch repair genes modulate risk of sporadic colorectal cancer? Tulupova E; Kumar R; Hanova M; Slyskova J; Pardini B; Polakova V; Naccarati A; Vodickova L; Novotny J; Halamkova J; Hemminki K; Vodicka P Mutat Res; 2008 Dec; 648(1-2):40-5. PubMed ID: 18851982 [TBL] [Abstract][Full Text] [Related]
42. Polymorphism of selected enzymes involved in detoxification and biotransformation in relation to lung cancer. Gresner P; Gromadzinska J; Wasowicz W Lung Cancer; 2007 Jul; 57(1):1-25. PubMed ID: 17337085 [TBL] [Abstract][Full Text] [Related]
43. [The interaction between microsomal epoxide hydrolase polymorphisms and indoor pollution in non small cell lung cancer]. Sun XW; Ma YY; Wang B Zhonghua Yu Fang Yi Xue Za Zhi; 2007 Jun; 41 Suppl():30-4. PubMed ID: 17767854 [TBL] [Abstract][Full Text] [Related]
44. Meta-analysis demonstrates lack of an association of microsomal epoxide hydrolase 1 polymorphisms with esophageal cancer risk. Hu JJ; Wang ZT; Li B Genet Mol Res; 2013 Oct; 12(4):4540-8. PubMed ID: 24222229 [TBL] [Abstract][Full Text] [Related]
45. The influence of interstitial collagenase-1 genotype polymorphism on colorectal cancer risk in Iranian population. Kouhkan F; Motovali-Bashi M; Hojati Z Cancer Invest; 2008 Oct; 26(8):836-42. PubMed ID: 18798060 [TBL] [Abstract][Full Text] [Related]
46. Bioequivalence revisited: influence of age and sex on CYP enzymes. Bebia Z; Buch SC; Wilson JW; Frye RF; Romkes M; Cecchetti A; Chaves-Gnecco D; Branch RA Clin Pharmacol Ther; 2004 Dec; 76(6):618-27. PubMed ID: 15592333 [TBL] [Abstract][Full Text] [Related]
47. Investigation of CTLA-4 and CD28 gene polymorphisms in a group of Turkish patients with colorectal cancer. Dilmec F; Ozgonul A; Uzunkoy A; Akkafa F Int J Immunogenet; 2008 Aug; 35(4-5):317-21. PubMed ID: 18680513 [TBL] [Abstract][Full Text] [Related]
49. DNA repair genetic polymorphisms and risk of colorectal cancer in the Czech Republic. Pardini B; Naccarati A; Novotny J; Smerhovsky Z; Vodickova L; Polakova V; Hanova M; Slyskova J; Tulupova E; Kumar R; Bortlik M; Barale R; Hemminki K; Vodicka P Mutat Res; 2008 Feb; 638(1-2):146-53. PubMed ID: 17991492 [TBL] [Abstract][Full Text] [Related]
50. CYP1A2 164 A-->C polymorphism, cigarette smoking, consumption of well-done red meat and risk of developing colorectal adenomas and carcinomas. Saebø M; Skjelbred CF; Brekke Li K; Bowitz Lothe IM; Hagen PC; Johnsen E; Tveit KM; Kure EH Anticancer Res; 2008; 28(4C):2289-95. PubMed ID: 18751408 [TBL] [Abstract][Full Text] [Related]
51. Genetic polymorphisms of smoking-related carcinogen detoxifying enzymes and head and neck cancer susceptibility. Lacko M; Oude Ophuis MB; Peters WH; Manni JJ Anticancer Res; 2009 Feb; 29(2):753-61. PubMed ID: 19331232 [TBL] [Abstract][Full Text] [Related]
52. EPHX1 Tyr113His and His139Arg polymorphisms in esophageal cancer risk: a meta-analysis. Tan X; He WW; Wang YY; Shi LJ; Chen MW Genet Mol Res; 2014 Jan; 13(1):649-59. PubMed ID: 24615030 [TBL] [Abstract][Full Text] [Related]
53. Genetically lowered microsomal epoxide hydrolase activity and tobacco-related cancer in 47,000 individuals. Lee J; Dahl M; Nordestgaard BG Cancer Epidemiol Biomarkers Prev; 2011 Aug; 20(8):1673-82. PubMed ID: 21653646 [TBL] [Abstract][Full Text] [Related]
54. [Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility]. Gu YF; Zhang ZD; Zhang SC; Zheng SH; Jia HY; Gu SX Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3064-8. PubMed ID: 18261353 [TBL] [Abstract][Full Text] [Related]
55. Polymorphism in the promoter region of the NFKB1 gene increases the risk of sporadic colorectal cancer in Swedish but not in Chinese populations. Lewander A; Butchi AK; Gao J; He LJ; Lindblom A; Arbman G; Carstensen J; Zhang ZY; Sun XF; Scand J Gastroenterol; 2007 Nov; 42(11):1332-8. PubMed ID: 17852842 [TBL] [Abstract][Full Text] [Related]
56. Inherited variation in carcinogen-metabolizing enzymes and risk of colorectal polyps. Goode EL; Potter JD; Bamlet WR; Rider DN; Bigler J Carcinogenesis; 2007 Feb; 28(2):328-41. PubMed ID: 16926176 [TBL] [Abstract][Full Text] [Related]
57. Cytochrome P2 polymorphisms and susceptibility to scleroderma following exposure to organic solvents. Povey A; Guppy MJ; Wood M; Knight C; Black CM; Silman AJ Arthritis Rheum; 2001 Mar; 44(3):662-5. PubMed ID: 11263781 [TBL] [Abstract][Full Text] [Related]
58. Polymorphisms in the microsomal epoxide hydrolase gene: role in lung cancer susceptibility and prognosis. Erkisi Z; Yaylim-Eraltan I; Turna A; Görmüs U; Camlica H; Isbir T Tumori; 2010; 96(5):756-63. PubMed ID: 21302624 [TBL] [Abstract][Full Text] [Related]
59. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. III. Influence of CYP genetic polymorphism on population differentiation of drug metabolism phenotype. Tomaszewski P; Kubiak-Tomaszewska G; Łukaszkiewicz J; Pachecka J Acta Pol Pharm; 2008; 65(3):319-29. PubMed ID: 18646551 [TBL] [Abstract][Full Text] [Related]
60. Association of Activity Altering Genotypes - Tyr113His and His139Arg in Microsomal Epoxide Hydrolase Enzyme with Esophageal Squamous Cell Carcinoma. Nabi S; Bhat GA; Iqbal B; Lone MM; Lone GN; Khan MA; Dar NA Nutr Cancer; 2019; 71(5):806-817. PubMed ID: 30633570 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]